Bacillus cereus extracellular vesicles act as shuttles for biologically active multicomponent enterotoxins.

3D-SIM microscopy Bacillus cereus Extracellular vesicles Host–pathogen interaction Multicomponent toxin Non-hemolytic enterotoxin SMase

Journal

Cell communication and signaling : CCS
ISSN: 1478-811X
Titre abrégé: Cell Commun Signal
Pays: England
ID NLM: 101170464

Informations de publication

Date de publication:
15 05 2023
Historique:
received: 14 03 2023
accepted: 19 04 2023
medline: 17 5 2023
pubmed: 16 5 2023
entrez: 15 5 2023
Statut: epublish

Résumé

Extracellular vesicles (EVs) from Gram-positive bacteria have gained considerable importance as a novel transport system of virulence factors in host-pathogen interactions. Bacillus cereus is a Gram-positive human pathogen, causing gastrointestinal toxemia as well as local and systemic infections. The pathogenicity of enteropathogenic B. cereus has been linked to a collection of virulence factors and exotoxins. Nevertheless, the exact mechanism of virulence factor secretion and delivery to target cells is poorly understood. Here, we investigate the production and characterization of enterotoxin-associated EVs from the enteropathogenic B. cereus strain NVH0075-95 by using a proteomics approach and studied their interaction with human host cells in vitro. For the first time, comprehensive analyses of B. cereus EV proteins revealed virulence-associated factors, such as sphingomyelinase, phospholipase C, and the three-component enterotoxin Nhe. The detection of Nhe subunits was confirmed by immunoblotting, showing that the low abundant subunit NheC was exclusively detected in EVs as compared to vesicle-free supernatant. Cholesterol-dependent fusion and predominantly dynamin-mediated endocytosis of B. cereus EVs with the plasma membrane of intestinal epithelial Caco2 cells represent entry routes for delivery of Nhe components to host cells, which was assessed by confocal microscopy and finally led to delayed cytotoxicity. Furthermore, we could show that B. cereus EVs elicit an inflammatory response in human monocytes and contribute to erythrocyte lysis via a cooperative interaction of enterotoxin Nhe and sphingomyelinase. Our results provide insights into the interaction of EVs from B. cereus with human host cells and add a new layer of complexity to our understanding of multicomponent enterotoxin assembly, offering new opportunities to decipher molecular processes involved in disease development. Video Abstract.

Sections du résumé

BACKGROUND
Extracellular vesicles (EVs) from Gram-positive bacteria have gained considerable importance as a novel transport system of virulence factors in host-pathogen interactions. Bacillus cereus is a Gram-positive human pathogen, causing gastrointestinal toxemia as well as local and systemic infections. The pathogenicity of enteropathogenic B. cereus has been linked to a collection of virulence factors and exotoxins. Nevertheless, the exact mechanism of virulence factor secretion and delivery to target cells is poorly understood.
RESULTS
Here, we investigate the production and characterization of enterotoxin-associated EVs from the enteropathogenic B. cereus strain NVH0075-95 by using a proteomics approach and studied their interaction with human host cells in vitro. For the first time, comprehensive analyses of B. cereus EV proteins revealed virulence-associated factors, such as sphingomyelinase, phospholipase C, and the three-component enterotoxin Nhe. The detection of Nhe subunits was confirmed by immunoblotting, showing that the low abundant subunit NheC was exclusively detected in EVs as compared to vesicle-free supernatant. Cholesterol-dependent fusion and predominantly dynamin-mediated endocytosis of B. cereus EVs with the plasma membrane of intestinal epithelial Caco2 cells represent entry routes for delivery of Nhe components to host cells, which was assessed by confocal microscopy and finally led to delayed cytotoxicity. Furthermore, we could show that B. cereus EVs elicit an inflammatory response in human monocytes and contribute to erythrocyte lysis via a cooperative interaction of enterotoxin Nhe and sphingomyelinase.
CONCLUSION
Our results provide insights into the interaction of EVs from B. cereus with human host cells and add a new layer of complexity to our understanding of multicomponent enterotoxin assembly, offering new opportunities to decipher molecular processes involved in disease development. Video Abstract.

Identifiants

pubmed: 37189133
doi: 10.1186/s12964-023-01132-1
pii: 10.1186/s12964-023-01132-1
pmc: PMC10184354
doi:

Substances chimiques

Enterotoxins 0
Sphingomyelin Phosphodiesterase EC 3.1.4.12
Virulence Factors 0
Bacterial Proteins 0

Types de publication

Video-Audio Media Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112

Informations de copyright

© 2023. The Author(s).

Références

Int J Mol Sci. 2019 Nov 14;20(22):
pubmed: 31739393
Sci Rep. 2020 Feb 20;10(1):3120
pubmed: 32080346
Reprod Fertil Dev. 2017 Oct;29(11):2157-2167
pubmed: 28248633
J Vis Exp. 2015 Jan 17;(95):50974
pubmed: 25650897
Microb Pathog. 2016 Apr;93:185-93
pubmed: 26924795
J Proteomics. 2018 Sep 15;187:28-38
pubmed: 29857065
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
PLoS One. 2013 Sep 10;8(9):e74748
pubmed: 24040335
Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19002-7
pubmed: 20956325
Environ Microbiol. 2003 Aug;5(8):631-40
pubmed: 12871230
J Extracell Vesicles. 2017 Jun 6;6(1):1324731
pubmed: 28717421
Nat Microbiol. 2019 Feb;4(2):362-374
pubmed: 30531979
Clin Microbiol Rev. 2010 Apr;23(2):382-98
pubmed: 20375358
Microbiology (Reading). 2000 Dec;146 Pt 12:3033-3039
pubmed: 11101661
J Extracell Vesicles. 2019 Apr 01;8(1):1596016
pubmed: 30988894
Adv Ther (Weinh). 2022 Mar;5(3):2100222
pubmed: 35310821
Toxins (Basel). 2020 Oct 06;12(10):
pubmed: 33036317
Appl Environ Microbiol. 2005 Dec;71(12):8214-20
pubmed: 16332805
Food Microbiol. 2020 Feb;85:103279
pubmed: 31500702
Infect Immun. 2012 Feb;80(2):832-8
pubmed: 22104106
Microbiology (Reading). 2004 Dec;150(Pt 12):3959-67
pubmed: 15583149
Mol Nutr Food Res. 2004 Dec;48(7):479-87
pubmed: 15538709
mBio. 2018 Apr 10;9(2):
pubmed: 29636428
Front Immunol. 2020 Feb 14;11:80
pubmed: 32117243
J Colloid Interface Sci. 2002 Dec 15;256(2):284-9
pubmed: 12573633
Infect Immun. 2012 Jun;80(6):1948-57
pubmed: 22409932
J Biol Chem. 2006 Jun 9;281(23):16157-67
pubmed: 16595670
BMC Immunol. 2014 Dec 09;15:60
pubmed: 25488836
Microbiol Spectr. 2019 May;7(3):
pubmed: 31111815
Infect Immun. 2020 Nov 16;88(12):
pubmed: 32989035
Food Microbiol. 2019 Dec;84:103276
pubmed: 31421762
Infect Immun. 2010 Sep;78(9):3813-21
pubmed: 20624910
Nat Commun. 2018 Apr 11;9(1):1379
pubmed: 29643357
Biochim Biophys Acta Biomembr. 2017 Mar;1859(3):459-466
pubmed: 27989744
J Clin Microbiol. 2002 Aug;40(8):3053-6
pubmed: 12149378
Nat Rev Microbiol. 2015 Oct;13(10):620-30
pubmed: 26324094
Infect Immun. 1995 Nov;63(11):4423-8
pubmed: 7591080
PLoS One. 2012;7(6):e38054
pubmed: 22701599
Anal Chem. 2016 May 17;88(10):5438-43
pubmed: 27119963
Front Microbiol. 2018 Jul 09;9:1502
pubmed: 30038605
Cell Microbiol. 2016 Nov;18(11):1508-1517
pubmed: 27529760
Microbiology (Reading). 2008 Mar;154(Pt 3):693-704
pubmed: 18310016
Proteomics. 2009 Dec;9(24):5425-36
pubmed: 19834908
BMC Microbiol. 2010 Nov 30;10:304
pubmed: 21118484
Nat Rev Microbiol. 2015 Oct;13(10):605-19
pubmed: 26373371
Front Cell Infect Microbiol. 2018 Aug 22;8:277
pubmed: 30186772
Biotechnol Lett. 2016 Jan;38(1):23-31
pubmed: 26437973
Trends Microbiol. 2021 May;29(5):458-471
pubmed: 33004259
Clin Proteomics. 2016 Mar 09;13:6
pubmed: 26962304
PLoS Pathog. 2009 Apr;5(4):e1000382
pubmed: 19360133
PLoS One. 2013 Apr 16;8(4):e61404
pubmed: 23613846
Nat Biotechnol. 2019 Apr;37(4):420-423
pubmed: 30778233
Nat Commun. 2017 Sep 7;8(1):481
pubmed: 28883390
Toxins (Basel). 2021 Jan 28;13(2):
pubmed: 33525722
Nat Rev Microbiol. 2019 Jan;17(1):13-24
pubmed: 30397270
Pathogens. 2021 Nov 23;10(12):
pubmed: 34959485
Mol Microbiol. 2009 Jun;72(6):1395-407
pubmed: 19432795
Mol Microbiol. 2014 Jul;93(1):183-98
pubmed: 24826903
J Proteomics. 2014 Jun 25;106:46-60
pubmed: 24769240
PLoS One. 2011;6(11):e27958
pubmed: 22114730
FEMS Microbiol Rev. 2019 May 1;43(3):273-303
pubmed: 30476045
Proc Natl Acad Sci U S A. 2020 Feb 11;117(6):3174-3184
pubmed: 31988111
Biol Pharm Bull. 2020;43(2):250-253
pubmed: 32009113
PLoS One. 2018 May 23;13(5):e0194346
pubmed: 29791442
Nat Commun. 2020 Feb 6;11(1):760
pubmed: 32029733
Front Microbiol. 2020 Jan 17;10:3026
pubmed: 32038523
mBio. 2018 Nov 20;9(6):
pubmed: 30459192
FEMS Microbiol Lett. 1996 Aug 1;141(2-3):151-6
pubmed: 8768516
mBio. 2023 Feb 28;14(1):e0357122
pubmed: 36744901
PLoS One. 2008 Jul 30;3(7):e2793
pubmed: 18665214
Microbiology (Reading). 2005 Jan;151(Pt 1):183-197
pubmed: 15632437
J Extracell Vesicles. 2019 Jun 24;8(1):1632099
pubmed: 31275533
Pediatr Transplant. 2015 Feb;19(1):E11-4
pubmed: 25323120
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Int J Food Microbiol. 2016 Sep 2;232:80-6
pubmed: 27257745
Nat Rev Microbiol. 2011 Dec 28;10(2):123-36
pubmed: 22203377
PLoS Pathog. 2016 Sep 01;12(9):e1005816
pubmed: 27583406
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
mBio. 2021 Aug 31;12(4):e0165721
pubmed: 34253061
PLoS One. 2013 Apr 30;8(4):e63104
pubmed: 23646182
Toxicon. 2014 Jan;77:49-57
pubmed: 24211313
PLoS One. 2013;8(1):e54661
pubmed: 23382935
Infect Immun. 2000 Sep;68(9):5269-76
pubmed: 10948154
Front Microbiol. 2015 Jun 10;6:560
pubmed: 26113843
Mol Cell Proteomics. 2010 Jul;9(7):1486-98
pubmed: 20368289

Auteurs

Tanja Buchacher (T)

Functional Microbiology, Institute of Microbiology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria.

Astrid Digruber (A)

Functional Microbiology, Institute of Microbiology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria.

Markus Kanzler (M)

Functional Microbiology, Institute of Microbiology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria.

Giorgia Del Favero (G)

Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Vienna, Austria.
Core Facility Multimodal Imaging, Faculty of Chemistry, University of Vienna, Vienna, Austria.

Monika Ehling-Schulz (M)

Functional Microbiology, Institute of Microbiology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria. monika.ehling-schulz@vetmeduni.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH